Bone Marrow Suppression Secondary to the COVID-19 Booster Vaccine: A Case Report

As of September 2021, SARS-CoV-2 booster shots became widely available in the US to ensure continued protection against the virus. A temporal relationship has been previously reported between the first or second dose of the COVID-19 vaccine and the development of thrombocytopenia. However, adverse e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shastri, Toral, Randhawa, Navkiran, Aly, Ragia, Ghouse, Masood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863340/
https://www.ncbi.nlm.nih.gov/pubmed/35210894
http://dx.doi.org/10.2147/JBM.S350290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863340/
https://www.ncbi.nlm.nih.gov/pubmed/35210894
http://dx.doi.org/10.2147/JBM.S350290

Ejemplares similares